Pfizer RSV Vaccine May Protect High-Risk Adults Ages 18-59

Respiratory syncytial virus: viral vaccine under investigation Hail | Stock | fake images a vaccine Pfizer showed the potential to…

Record Funding Boosts Denver-Boulder Life Sciences Market

This story is part of CNBC's quarterly Cities of Success series, which explores cities that have transformed themselves into business…